Recipharm divests Portuguese distribution business and ophthalmology company for approximately EUR 31 million
(WorldNews Italy)

Recipharm divests Portuguese distribution business and ophthalmology company for approximately EUR 31 million Recipharm AB (publ) today announces the divestment of the Medicamenta business unit, conducted within the subsidiary Lusomedicamenta - Sociedade T&eaigu;cnica Farmacêutica, S.A., to Laboratório Medinfar - Produtos Farmacêuticos. In a separate transaction, 100 per cent of the shares in the subsidiary DAVI II Farmacêutica, S.A. (`DAVI`) has been divested to PIHEX - INVESTIMENTOS IMOBILIÁRIOS, LDA. Recipharm`s Contract Manufacturing activities in Portugal will remain unchanged. The...